Enhanced oxidative stress is an early event during development of Alzheimer-like pathologies in presenilin conditional knock-out mice.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neuroscience Letters

• Publication date

  2008-07-25

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.neulet.2008.05.050PMID 18539391
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Environment enrichment rescues the neurodegenerative phenotypes in presenilins‐deficient mice

  2007cited by this paper
• Mutations in amyloid precursor protein and presenilin‐1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid β‐peptide (1–42), H2O2 and kainic acid: implications for Alzheimer's disease

  2006cited by this paper
• Proteomic analysis for protein carbonyl as an indicator of oxidative damage in senescence-accelerated mice

  2006cited by this paper
• Regulation of CRE-dependent transcription by presenilins: prospects for therapy of Alzheimer's disease.

  2006cited by this paper
• Differential neuronal expression of manganese superoxide dismutase in Alzheimer's disease.

  2005cited by this paper
• Brain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosis

  2004cited by this paper
• Forebrain degeneration and ventricle enlargement caused by double knockout of Alzheimer's presenilin-1 and presenilin-2.

  2004cited by this paper
• Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration.

  2004cited by this paper
• Presenilin-1-deficient neurons are nitric oxide-dependently killed by hydrogen peroxide in vitro.

  2004cited by this paper
• Brain β-Amyloid Accumulation in Transgenic Mice Expressing Mutant Superoxide Dismutase 1

  2004cited by this paper
• Proteomic identification of specific oxidized proteins in ApoE-knockout mice: relevance to Alzheimer's disease.

  2004cited by this paper
• Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice.

  2004cited by this paper
• Reduced β-Amyloid Production and Increased Inflammatory Responses in Presenilin Conditional Knock-out Mice*

  2004cited by this paper
• Protein carbonylation in human diseases.

  2003cited by this paper
• Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).

  2002cited by this paper
• Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces.

  2001cited by this paper
• Oxidative Damage Is the Earliest Event in Alzheimer Disease

  2001cited by this paper
• Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide.

  2001cited by this paper
• Deficiency of presenilin‐1 increases calcium‐dependent vulnerability of neurons to oxidative stress in vitro

  2001cited by this paper
• Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency.

  1999cited by this paper
• Mice lacking both presenilin genes exhibit early embryonic patterning defects.

  1999cited by this paper
• A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain

  1999cited by this paper
• Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein

  1998cited by this paper
• Skeletal and CNS defects in Presenilin-1-deficient mice.

  1997cited by this paper
• Presenilins and Alzheimer's disease.

  1997cited by this paper
• Protein Oxidation in Aging, Disease, and Oxidative Stress*

  1997cited by this paper
• 4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease

  1997cited by this paper
• Phosphorylation, Subcellular Localization, and Membrane Orientation of the Alzheimer's Disease-associated Presenilins*

  1997cited by this paper
• Oxidative stress hypothesis in Alzheimer's disease.

  1997cited by this paper
• The presenilins and Alzheimer's disease.

  1997cited by this paper
• Early and transient increase in oxidative stress in the cerebral cortex of senescence-accelerated mouse.

  1996cited by this paper
• Decreased Catalase Activity but Unchanged Superoxide Dismutase Activity in Brains of Patients with Dementia of Alzheimer Type

  1995cited by this paper
• Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation

  1995cited by this paper
• Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease

  1995cited by this paper
• Evidence of an oxidative challenge in the Alzheimer's brain

  1994cited by this paper
• Carbonyl assays for determination of oxidatively modified proteins.

  1994cited by this paper
• Autopsy Samples of Alzheimer's Cortex Show Increased Peroxidation In Vitro

  1990cited by this paper

• Influence of Alzheimer’s associated Aβ oligomers and oxidative stress on blood–brain barrier dysfunction

  2025cites this paper
• Synthesis of Ethylphosphonate Curcumin Mimics: Substituents Allow Switching Between Cytotoxic and Cytoprotective Activities

  2025cites this paper
• Piperazine Derivatives Attenuate Scopolamine‐Induced Memory Deficits by Modulating Neuroinflammation and Oxidative Stress via the NF‐κB/TNF‐α/COX‐2 Pathway

  2025cites this paper
• Recent advances in the therapeutic insights of thiazole scaffolds as acetylcholinesterase inhibitors.

  2025cites this paper
• In silico molecular modeling and in vitro biological screening of novel benzimidazole-based piperazine derivatives as potential acetylcholinesterase and butyrylcholinesterase inhibitors

  2024cites this paper
• Barbiturate-sulfonate hybrids as potent cholinesterase inhibitors: design, synthesis and molecular modeling studies.

  2024cites this paper
• New indole derivatives as multitarget anti-Alzheimer's agents: synthesis, biological evaluation and molecular dynamics.

  2023cites this paper
• Synthesis and molecular docking simulation of new benzimidazole–thiazole hybrids as cholinesterase inhibitors

  2023cites this paper
• Hydrazone-sulfonate hybrids as potential cholinesterase inhibitors: design, synthesis and molecular modeling simulation.

  2023cites this paper
• Exploring the Multitarget Activity of Wedelolactone against Alzheimer’s Disease: Insights from In Silico Study

  2023cites this paper
• Flavonoids: The Innocuous Agents Offering Protection Against Alzheimer's Disease Through Modulation Of Proinflammatory And Apoptotic Pathways.

  2022cites this paper
• Analysis and Comparison of Mouse and Human Brain Gangliosides via Two-Stage Matching of MS/MS Spectra

  2022cites this paper
• Synthesis, In Silico and Pharmacological Evaluation of New Thiazolidine-4-Carboxylic Acid Derivatives Against Ethanol-Induced Neurodegeneration and Memory Impairment

  2022cites this paper
• Synthesis, in silico and Pharmacological Evaluation of New Thiazolidine-4-Carboxylic Acid Derivatives Against Ethanol-Induced Neurodegeneration and Memory Impairment [Retraction]

  2022cites this paper
• Alzheimer’s Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer’s Disease and Type 2 Diabetes

  2022cites this paper
• Luminescent lanthanide complexes for reactive oxygen species biosensing and possible application in Alzheimer’s diseases

  2021cites this paper
• Synthesis and Biological Evaluation of Benzimidazole Derivatives as Potential Neuroprotective Agents in an Ethanol-Induced Rodent Model.

  2021cites this paper
• Design, synthesis, and biological evaluation of diosgenin-indole derivatives as dual-functional agents for the treatment of Alzheimer's disease.

  2021cites this paper
• Recent Progress on the Drug Development for the Treatment of Alzheimer's Disease Especially on Inhibition of Amyloid-Peptide Aggregation.

  2020cites this paper
• Design, Synthesis and Biological Evaluation of Xanthone Derivatives for Possible Treatment of Alzheimer's Disease Based on Multi‐Target Strategy

  2020cites this paper
• Simultaneous exposure to noise and carbon monoxide increases the risk of Alzheimer's disease: a literature review

  2020cites this paper
• On the role of synthesized hydroxylated chalcones as dual functional amyloid-β aggregation and ferroptosis inhibitors for potential treatment of Alzheimer's disease.

  2019cites this paper
• Synthesis and evaluation of isoprenylation-resveratrol dimer derivatives against Alzheimer's disease.

  2019cites this paper
• Inhibitory effect of tartrate against phosphate-induced DJ-1 aggregation.

  2018cites this paper
• Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease.

  2018cites this paper
• Mannich‐Benzimidazole Derivatives as Antioxidant and Anticholinesterase Inhibitors: Synthesis, Biological Evaluations, and Molecular Docking Study

  2017cites this paper
• Rational Design and Multibiological Profiling of Novel Donepezil-Trolox Hybrids against Alzheimer's Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties.

  2017cites this paper
• Insulin resistance in Alzheimer's disease

  2017cites this paper
• Dietary Modulation of Oxidative Stress in Alzheimer’s Disease

  2017influential citation
• Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer's disease based on the fusion of donepezil and melatonin.

  2016cites this paper
• Dipotassium N-stearoyltyrosinate ameliorated pathological injuries in triple-transgenic mouse model of Alzheimer's disease.

  2016cites this paper
• Searching for Multi-Targeting Neurotherapeutics against Alzheimer’s: Discovery of Potent AChE-MAO B Inhibitors through the Decoration of the 2H-Chromen-2-one Structural Motif

  2016cites this paper
• Chitosan oligosaccharides alleviate cognitive deficits in an amyloid-β1-42-induced rat model of Alzheimer's disease.

  2016cites this paper
• Neuroprotective effects of liquiritin on cognitive deficits induced by soluble amyloid-β1–42 oligomers injected into the hippocampus

  2016cites this paper
• Brain Amyloid-β Plays an Initiating Role in the Pathophysiological Process of the PS1V97L-Tg Mouse Model of Alzheimer’s Disease

  2016cites this paper
• Combination of ESI and MALDI mass spectrometry for qualitative, semi-quantitative and in situ analysis of gangliosides in brain

  2016cites this paper
• Free Superoxide is an Intermediate in the Production of H2O2 by Copper(I)-Aβ Peptide and O2.

  2016cites this paper
• Novel 8‐Hydroxyquinoline Derivatives as Multitarget Compounds for the Treatment of Alzheimer′s Disease

  2016cites this paper
• Natural Compounds as Therapeutic Agents for Amyloidogenic Diseases

  2015cites this paper
• Biflavonoids as Potential Small Molecule Therapeutics for Alzheimer's Disease.

  2015cites this paper
• Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer's disease.

  2015cites this paper
• Discovery of indanone derivatives as multi-target-directed ligands against Alzheimer's disease.

  2014cites this paper
• New melatonin-N,N-dibenzyl(N-methyl)amine hybrids: potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease.

  2014cites this paper
• Design, synthesis and biological evaluation of imine resveratrol derivatives as multi-targeted agents against Alzheimer's disease.

  2014cites this paper
• Brain metabolic dysfunction at the core of Alzheimer's disease.

  2014cites this paper
• Decreasing oxidative stress and neuroinflammation with a multifunctional peptide rescues memory deficits in mice with Alzheimer disease.

  2014cites this paper
• Synthesis and evaluation of indole based molecules for treatment of oxidative stress related diseases.

  2014cites this paper
• Oxidative stress in farmed minks with self-biting behavior

  2013cites this paper
• Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.

  2013cites this paper
• Insulin Resistance and Metabolic Failure Underlie Alzheimer Disease

  2013cites this paper
• Triangulated Mal-Signaling in Alzheimer's Disease: Roles of Neurotoxic Ceramides, ER Stress, and Insulin Resistance Reviewed

  2012cites this paper
• Multitarget-directed benzylideneindanone derivatives: anti-β-amyloid (Aβ) aggregation, antioxidant, metal chelation, and monoamine oxidase B (MAO-B) inhibition properties against Alzheimer's disease.

  2012cites this paper
• Protective Effects of Troxerutin on β-Amyloid (1-42)-Induced Impairments of Spatial Learning and Memory in Rats

  2012cites this paper
• Ligustrazine Phosphate Ethosomes for Treatment of Alzheimer’s Disease, In Vitro and in Animal Model Studies

  2012cites this paper
• New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties.

  2012cites this paper
• Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseases.

  2012cites this paper
• Age-Dependent and Tissue-Related Glutathione Redox Status in a Mouse Model of Alzheimer's Disease

  2012cites this paper
• Erratum to: Protective Effects of Troxerutin on β-Amyloid (1-42)-Induced Impairments of Spatial Learning and Memory in Rats

  2012cites this paper
• Rutin inhibits β-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines.

  2012cites this paper
• Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin resistance diseases

  2012cites this paper
• Antioxidant proteins TSA and PAG interact synergistically with Presenilin to modulate Notch signaling in Drosophila

  2011cites this paper
• Combined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between alzheimer’s disease and other dementias

  2011cites this paper
• Benzenediol-berberine hybrids: multifunctional agents for Alzheimer's disease.

  2011cites this paper
• Neuroprotective effects of Abacopterin E from Abacopteris penangiana against oxidative stress-induced neurotoxicity.

  2011cites this paper
• Neurobiological aspects of Alzheimer's disease

  2011cites this paper
• Treatment with a γ-Ketoaldehyde Scavenger Prevents Working Memory Deficits in hApoE4 Mice

  2011cites this paper
• Presenilin transgenic mice as models of Alzheimer’s disease

  2010cites this paper
• Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties.

  2010cites this paper
• Proteomic-based genotyping in a mouse model of trait anxiety exposes disease-relevant pathways

  2010cites this paper
• Alterations in the red blood cell membrane proteome in alzheimer's subjects reflect disease-related changes and provide insight into altered cell morphology

  2010cites this paper
• Brain Mitochondrial Dysfunction in Ovariectomized Mice Injected with d-Galactose

  2010cites this paper
• Fourier transform infrared imaging showing reduced unsaturated lipid content in the hippocampus of a mouse model of Alzheimer's disease.

  2010cites this paper
• Redox Proteomic Analysis of Carbonylated Brain Proteins in Mild Cognitive Impairment and Early Alzheimer's Disease

  2010cites this paper
• Cardiomyocyte Contractile Dysfunction in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease

  2009cites this paper
• INVESTIGATIONS OF S-GLUTATHIONYLATION OF BRAIN PROTEINS IN THE PROGRESSION OF ALZHEIMER'S DISEASE AND OF A POTENTIAL GLUTATIONE MIMETIC AS A TREATMENT OF ALZHEIMER'S DISEASE

  2009cites this paper
• Methods and Applications of Alzheimer's Disease Assays

  2009cites this paper
• Involvement of paraoxonase 1 genetic variants in Alzheimer’s disease neuropathology

  2009cites this paper
• An Integrative View of the Role of Oxidative Stress, Mitochondria and Insulin in Alzheimer's Disease

  2009cites this paper
• N-Acetylcysteine Prevents Mitochondria from Oxidative Injury Induced by Conventional Peritoneal Dialysate in Human Peritoneal Mesothelial Cells

  2009cites this paper
• Oxidative damage increased in presenilin1/presenilin2 conditional double knockout mice

  2009influential citation
• Genetic markers of neurodegeneration: a role for paraoxonase 1 in sporadic Alzheimer's disease?

  2009cites this paper
• Molecular Profiling Reveals Diversity of Stress Signal Transduction Cascades in Highly Penetrant Alzheimer's Disease Human Skin Fibroblasts

  2009cites this paper
• Tacrine–Melatonin Hybrids as Multifunctional Agents for Alzheimer's Disease, with Cholinergic, Antioxidant, and Neuroprotective Properties

  2009cites this paper
• Becker Digital Commons@Becker

  year unknowncites this paper
• Molecular Neurodegeneration Increased Dj-1 Expression under Oxidative Stress and in Alzheimer's Disease Brains

  year unknowncites this paper